Premium Information is available for this item - Upgrade for $1 a day
5895-01-582-0511
Graphix Equalizer
5895015820511 015820511 231
INC: 77777
![]()
January 2023
2

Marketplace 5895-01-582-0511
Request a Quotation from participating marketplace vendors
Related Documents 5895-01-582-0511 2+ Documents (More...)
5895015820511 015820511,231 Day 5895-01-582-0511 RQST Updated Every Day 5895-01-582-0511 RQST NE Related
Documents 5895-01-582-0511 5895015820511 015820511,231 Day 5895-01-582-0511 RQST Updated Every Day 5895
Restrictions 5895-01-582-0511
5895-01-582-0511 is a Graphix Equalizer that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item has been confirmed as a Critical Munitions List Item or a Sensitive Commerce Control List Item and cannot be in the possession of any party anywhere in the World who is not an authorized NATO Government. Any other possessor of this item should mutilate it now as possession violates international and local laws. This item is a confirmed Commerce Control List Item (CCLI). This item is not suspected to be hazardous. This item does not contain a precious metal.
End Users 5895-01-582-0511
- Turkey (ZW01)
- Effective Date:
- 1 Feb 2010
Approved Sources 5895-01-582-0511
- Part Number
- Manufacturer
- Status
- 231
- Manufacturer
- 60340 - Dbx Inc (Active)
- Primary Buy
- Primary Buy
Datasheet 5895-01-582-0511
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- Special Features [FEAT]
- Two 31-Band, 1/3 Octave Constant Q Frequency Bands, 12Db Per Octave 40Hz Low Cut Filter, Front Panel Bypass Switch, 4 Segment Led Ladders For Monitoring Output Levels, Xlr And Trs Inpts And Outputs, Internal Toroidal Transformer, Dynamic Range Of Greater Than 108Db
Similar Supply Items to 5895-01-582-0511


















Freight Information 5895-01-582-0511
5895-01-582-0511 has freight characteristics managed by Turkey.. 5895-01-582-0511 has a variance between NMFC and UFC when transported by rail and the description should be consulted.